Follicular Lymphoma and Marginal Zone Lymphoma
2 clinical trials · Condition
◉ Watch Follicular Lymphoma and Marginal Zone Lymphoma
| Record | Firm | Date |
|---|---|---|
| MIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphoma (NCT04834024) | Beijing Mabworks Biotech Co., Ltd. | 2021-06-02 |
| MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL) (NCT04110301) | Beijing Mabworks Biotech Co., Ltd. | 2019-11-28 |
Track Follicular Lymphoma and Marginal Zone Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.